U.S. markets closed
  • S&P 500

    3,970.99
    +22.27 (+0.56%)
     
  • Dow 30

    32,237.53
    +132.28 (+0.41%)
     
  • Nasdaq

    11,823.96
    +36.56 (+0.31%)
     
  • Russell 2000

    1,734.92
    +14.63 (+0.85%)
     
  • Crude Oil

    69.20
    -0.76 (-1.09%)
     
  • Gold

    1,981.00
    -14.90 (-0.75%)
     
  • Silver

    23.36
    +0.11 (+0.47%)
     
  • EUR/USD

    1.0763
    -0.0073 (-0.68%)
     
  • 10-Yr Bond

    3.3800
    -0.0260 (-0.76%)
     
  • GBP/USD

    1.2232
    -0.0057 (-0.46%)
     
  • USD/JPY

    130.6700
    -0.1190 (-0.09%)
     
  • Bitcoin USD

    27,769.41
    +6.91 (+0.02%)
     
  • CMC Crypto 200

    597.33
    -21.06 (-3.41%)
     
  • FTSE 100

    7,405.45
    -94.15 (-1.26%)
     
  • Nikkei 225

    27,385.25
    -34.36 (-0.13%)
     

Why CureVac's Shares Jumped on Tuesday

Why CureVac's Shares Jumped on Tuesday

Shares of CureVac (NASDAQ: CVAC) rose as much as 19.1% on Tuesday. Despite the rise, CureVac is down more than 59% over the past year, though it is now up more than 61% over the past three months. Investors continued to flock to the healthcare stock after the biotech announced late Friday that several of its messenger RNA vaccines were doing well in early trials.